Pacific Edge CEO says Labour needs to re-think R&D tax credits
David Darling says the tax credit won't help his listed company which has just reported a narrowed $19.7 million loss.
Hot Topic
Summer features
David Darling, chief executive of Dunedin-based cancer diagnostics company Pacific Edge, says the government’s proposed research and development tax scheme has “limited value” to young growth companies like his own.
The listed company has just reported a narrowed $19.7 million loss for the year
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Fiona Rotherham
Wed, 30 May 2018
Wed, 30 May 2018
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Pacific Edge CEO says Labour needs to re-think R&D tax credits
75140